METHYLDOPA for Renal hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 26 adverse event reports in the FDA FAERS database where METHYLDOPA was used for Renal hypertension.
Most Reported Side Effects for METHYLDOPA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 1,028 | 39.5% | 48 | 156 |
| Premature baby | 792 | 30.4% | 21 | 156 |
| Maternal exposure during pregnancy | 623 | 23.9% | 3 | 237 |
| Premature delivery | 519 | 19.9% | 1 | 156 |
| Exposure during pregnancy | 502 | 19.3% | 5 | 155 |
| Low birth weight baby | 350 | 13.4% | 14 | 75 |
| Foetal growth restriction | 172 | 6.6% | 9 | 53 |
| Drug ineffective | 162 | 6.2% | 1 | 80 |
| Live birth | 153 | 5.9% | 0 | 100 |
| Off label use | 152 | 5.8% | 1 | 58 |
| Pre-eclampsia | 110 | 4.2% | 0 | 64 |
| Atrial septal defect | 104 | 4.0% | 1 | 8 |
| Dyspnoea | 93 | 3.6% | 0 | 67 |
| Hypertension | 85 | 3.3% | 2 | 56 |
| Small for dates baby | 80 | 3.1% | 0 | 4 |
Other Indications for METHYLDOPA
Hypertension (954)
Product used for unknown indication (813)
Foetal exposure during pregnancy (206)
Gestational hypertension (87)
Pre-eclampsia (77)
Essential hypertension (43)
Blood pressure increased (33)
Blood pressure management (23)
Blood pressure measurement (19)
Drug therapy (17)